Asia Pacific Manufacturing Execution System (MES) In Life Sciences Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2033–COVID-19 Impact and Regional Analysis– by Offering (Software and Services), Deployment (On-Premises and Cloud), Organization Size (SMEs and Large Enterprises), and Application (Pharmaceutical, Biotechnology, and Medical Devices)

No. of Pages: 144    |    Report Code: BMIRE00028407    |    Category: Technology, Media and Telecommunications

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Manufacturing Execution System (MES) In Life Sciences Market
Free Sample Buy Now

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Manufacturing Execution System in Life Sciences Market – By Offering

1.3.2        Asia Pacific Manufacturing Execution System in Life Sciences Market – By Deployment

1.3.3        Asia Pacific Manufacturing Execution System in Life Sciences Market – By Organization Size

1.3.4        Asia Pacific Manufacturing Execution System in Life Sciences Market – By Application

1.3.5        Asia Pacific Manufacturing Execution System in Life Sciences Market – By Country

2.           Asia Pacific Manufacturing Execution System in Life Sciences Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Manufacturing Execution System in Life Sciences Market – Market Landscape

4.1         Overview

4.2         Asia Pacific PEST Analysis

4.3         Ecosystem Analysis

4.4         Expert Opinion

5.           Asia Pacific Manufacturing Execution System in Life Sciences Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Need for Compliance with Regulatory Framework

5.1.2        Requirement of Accurate Real-Time Data in Production Management Process

5.2         Market Restraints

5.2.1        High Cost and Lack of Flexibility

5.3         Market Opportunities

5.3.1        Rising Application in Cell and Gene Therapy Sector

5.4         Future Trends

5.4.1        Shift from Legacy to Modern MES

5.4.2        Rise in Adoption of Pharma 4.0

5.5         Impact Analysis of Drivers and Restraints

6.           Manufacturing Execution System in Life Sciences Market – Asia Pacific Analysis

6.1         Asia Pacific Manufacturing Execution System in Life Sciences Market Overview

6.2         Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

7.           Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Offering

7.1         Overview

7.2         Asia Pacific Manufacturing Execution System in Life Sciences Market, By Offering (2022 and 2033)

7.3         Software

7.3.1        Overview

7.3.2        Software: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

7.4         Services

7.4.1        Overview

7.4.2        Services: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

8.           Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Deployment

8.1         Overview

8.2         Asia Pacific Manufacturing Execution System in Life Sciences Market, By Deployment (2022 and 2033)

8.3         On-Premises

8.3.1        Overview

8.3.2        On-Premises: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

8.4         Cloud

8.4.1        Overview

8.4.2        Cloud: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

9.           Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Organization Size

9.1         Overview

9.2         Asia Pacific Manufacturing Execution System in Life Sciences Market, By Organization Size (2022 and 2033)

9.3         SMEs

9.3.1        Overview

9.3.2        SMEs: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

9.4         Large Enterprises

9.4.1        Overview

9.4.2        Large Enterprises: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

10.        Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Application

10.1      Overview

10.2      Asia Pacific Manufacturing Execution System in Life Sciences Market, By Application (2022 and 2033)

10.3      Pharmaceutical

10.3.1     Overview

10.3.2     Pharmaceutical: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

10.4      Biotechnology

10.4.1     Overview

10.4.2     Biotechnology: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

10.5      Medical Devices

10.5.1     Overview

10.5.2     Medical Devices: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

11.        Asia Pacific Manufacturing Execution System in Life Sciences Market Analysis – By Country

11.1      Overview

11.1.1     Asia Pacific Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)

11.1.1.1       Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.1.3       Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.1.4       Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.1.5       Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.1.6       Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.2       China: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       China: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.2.3       China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.2.4       China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.2.5       China: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.2.6       China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.3       India: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       India: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.3.3       India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.3.4       India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.3.5       India: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.3.6       India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.4       Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.4.3       Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.4.4       Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.4.5       Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.4.6       Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.5       South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.5.1       Overview

11.1.1.5.2       South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.5.3       South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.5.4       South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.5.5       South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.5.6       South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

11.1.1.6       Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.6.1       Overview

11.1.1.6.2       Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

11.1.1.6.3       Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)

11.1.1.6.4       Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)

11.1.1.6.5       Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)

11.1.1.6.6       Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)

12.        Industry Landscape

12.1      Overview

12.2      Market Initiatives, Expansions, and Strategic Developments

12.3      New Product/Feature Development

12.4      Mergers and Acquisitions

12.5      Agreements, Collaborations, and Joint Ventures

13.        Company Profiles

13.1      ATS Global B.V.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Atachi Systems

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Emerson Electric Co

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      LZ Lifescience Limited

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Rockwell Automation Inc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Schneider Electric SE

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Siemens AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Word Index

 

 

LIST OF TABLES

Table 1.             Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2023 (US$ Million)

Table 2.             Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 3.             Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 4.             Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 5.             Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 6.             China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 7.             China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 8.             China: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 9.             China: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 10.          India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 11.          India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 12.          India: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 13.          India: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 14.          Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 15.          Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 16.          Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 17.          Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 18.          South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 19.          South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 20.          South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 21.          South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 22.          Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)

Table 23.          Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)

Table 24.          Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)

Table 25.          Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)

Table 26.          List of Abbreviation

 

 

LIST OF FIGURES

Figure 1.           Asia Pacific Manufacturing Execution System in Life Sciences Market Segmentation

Figure 2.           Asia Pacific Manufacturing Execution System in Life Sciences Market Segmentation, By Country

Figure 3.           Asia Pacific Manufacturing Execution System in Life Sciences Market Overview

Figure 4.           Services Held Largest Share Of Offering Segment In Asia Pacific Manufacturing Execution System in Life Sciences Market

Figure 5.           India Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Asia Pacific Manufacturing Execution System in Life Sciences Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 10.        Asia Pacific Manufacturing Execution System in Life Sciences Market Revenue Share, By Offering (2022 and 2033)

Figure 11.        Software: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 12.        Services: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 13.        Asia Pacific Manufacturing Execution System in Life Sciences Market Revenue Share, By Deployment (2022 and 2033)

Figure 14.        On-Premises: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 15.        Cloud: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 16.        Asia Pacific Manufacturing Execution System in Life Sciences Market Revenue Share, By Organization Size (2022 and 2033)

Figure 17.        SMEs: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 18.        Large Enterprises: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 19.        Asia Pacific Manufacturing Execution System in Life Sciences Market Revenue Share, By Application (2022 and 2033)

Figure 20.        Pharmaceutical: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 21.        Biotechnology: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 22.        Medical Devices: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)

Figure 23.        Asia Pacific Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)

Figure 24.        Australia: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 25.        China: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 26.        India: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 27.        Japan: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 28.        South Korea: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

Figure 29.        Rest of Asia Pacific: Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)

 

The List of Companies - Asia Pacific Manufacturing Execution System (MES) In Life Sciences Market

  1. Atachi Systems
  2. ATS Global B.V.
  3. Emerson Electric Co
  4. LZ Lifescience Limited
  5. Rockwell Automation Inc
  6. Schneider Electric SE
  7. Siemens AG
asia-pacific-manufacturing-execution-system-mes-in-life-sciences-market